YUNGJIN PHARM. CO. LTD(KR:003520)
₩762.00-19.00 (-2.43%)
KR:003520
YUNGJIN PHARM. CO. LTD Revenue
₩762.00
At close:-19.00 (-2.43%)
Want to see KR:003520 full AI Analyst Report?
YUNGJIN PHARM. CO. LTD (003520) Revenue
YUNGJIN PHARM. CO. LTD Revenue
YUNGJIN PHARM. CO. LTD had a revenue of 61.58B in the quarter ending Jun 30, 2026, with -3.42%. This bring the company's revenue in the last twelve months to 253.00B, Decreased 0.37%. In the fiscal year ending Dec 31, 2025, YUNGJIN PHARM. CO. LTD had annual revenue of 254.26B with 0.88% growth.
- Revenue (ttm)
- 253.00B
- Revenue Growth
- 1.83%
- P/S Ratio
- 0.55
- Revenue/Employee
- KRW 406,159,575
- Employees
- 626
- Market Cap
- KRW 139.36B
Revenue Chart
YUNGJIN PHARM. CO. LTD Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 254.26B | 2.22B | 0.88% |
| Dec 31, 2024 | 252.04B | 17.14B | 7.30% |
| Dec 31, 2023 | 234.90B | 16.52B | 7.57% |
| Dec 31, 2022 | 218.38B | 22.31B | 11.38% |
| Dec 31, 2021 | 196.07B | -12.40B | -5.95% |
| Dec 31, 2020 | 208.46B | -12.05B | -5.47% |
| Dec 31, 2019 | 220.52B | 34.11B | 18.30% |
| Dec 31, 2018 | 186.41B | -8.60B | -4.41% |
| Dec 31, 2017 | 195.01B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

